Eugia US LLC 2024-03-13 Health serious FDA
Health · FDA · Recall #FDA-D-0366-2024
Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL… Recall
Issued March 13, 2024 · Eugia US LLC
In March 2024, Eugia US LLC recalled the Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Dissolution Specifications
What you should do
- 1 Stop using Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Eugia US LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Eugia US LLC
- Category
- Health
- Recall date
- March 13, 2024
- Units affected
- Not reported
- Sold at
- OH, TN, LA, MS
- Recall number
- FDA-D-0366-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- Eugia US LLC has 13 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.